Livedr.org

..steps
step1.do intern in china after 4/4.5 years
2.give mci screen
3.pass mci
4.get temp.reg no. from mci
5.go to kerala med coll/dist hosp
6.do one year internship
7.go back mci,give your intern log book from med coll to mci
8.get your perm.reg. no.
9.come back to kerala,go for your t/c reg no.
10.apply for aipg

simply and easy to remember steps got more questions.. do ask

all india medical students consortium????

chinese to english medical diseases and terms e book for indian medical students in china useful for hsk and mci screening test


Please Read Very Carefully - INFORM ALL YOUR FRIENDS & FAMILY MEMBERS

India has become a dumping ground for banned drugs; also the business for production of banned drugs is booming. Plz make sure that u buy drugs only if prescribed by a doctor(Also, ask which company manufactures it, this would help to ensure that u get what is prescribed at the Drug Store) and that also from a reputed drug store. Not many people know about these banned drugs and consume them causing a lot of damage to themselves. We forward Jokes and other junk all the time. This is far more important.

DANGEROUS DRUGS HAVE BEEN GLOBALLY DISCARDED BUT ARE AVAILABLE IN INDIA . The most common ones are action 500 & Nimulid.

PHENYLPROPANOLAMINE:
cold and cough. Reason for ban : stroke.
Brand name : Vicks Action-500
ANALGIN:
This is a pain-killer. Reason for ban: Bone marrow depression.
Brand name: Novalgin
CISAPRIDE:
Acidity, constipation. Reason for ban : irregular heartbeat
Brand name : Ciza, Syspride
DROPERIDOL:
Anti-depressant. Reason for ban : Irregular heartbeat.
Brand name : Droperol
FURAZOLIDONE:
Antidiarrhoeal. Reason for ban : Cancer.
Brand name : Furoxone, Lomofen
NIMESULIDE:
Painkiller, fever. Reason for ban : Liver failure.
Brand name : Nise, Nimulid
NITROFURAZONE:
Antibacterial cream. Reason for ban : Cancer.
Brand name : Furacin
PHENOLPHTHALEIN:
Laxative. Reason for ban : Cancer.
Brand name : Agarol
OXYPHENBUTAZONE:
Non-steroidal anti-inflammatory drug. Reason for ban : Bone marrow depression.
Brand name : Sioril
PIPERAZINE:
Anti-worms. Reason for ban : Nerve damage.
Brand name : Piperazine
QUINIODOCHLOR:
Anti-diarrhoeal. Reason for ban : Damage to sight.
Brand name: Enteroquinol

PLZ SPREAD THE INFO….IF U CAN……FOR BETTER FUTURE

handigarh, Nov 05, 2008 (Asia Pulse Data Source via COMTEX) — MRK | Quote | Chart | News | PowerRating — Even as global financial slowdown is forcing companies to retrench jobs, MSD Pharmaceuticals– a subsidiary of US-based Merck & Co today said it will employ 1,500 people in the next two years to strengthen its sales and marketing network and become a leading company by 2015.

“We will be doubling our staff strength in India in next two years as part of our plans to consolidate our marketing network in the country which will further help us achieve our aim of listing among first five pharma companies by 2015,” MSD Pharmaceuticals Managing Director Naveen A Rao said.

At present, the company has a total staff strength of 700 in India.

With an objective of expanding its product portfolio in the country, MSD Pharmaceuticals also plans to launch wide range of vaccines and medicines every six months.

“We have plans to launch our product range including vaccine and medicine which are relevant to India,” he said.

Adding further he said, the company would launch its vaccine for hepatitis-A, Chickenpox and rotavirus. In addition, it would also bring out medicines for cardiovascular disease, dyspledemia and asthma.

The company has about six products– four medicines and two vaccine for therapeutic areas namely, critical care, cardiovascular and metabolic at present in the Indian market.

The company is also looking at project-based agreements with major pharma companies for developing molecules and providing leads as part of its research and development initiative. “We have such arrangements with Ranbaxy, Nicholas Piramal and Advinus and we are also in negotiations with several other companies for these collaborations,” he said.

MSD Pharmaceuticals has also collaborated with Indian Council of Medical Research in pubic private partnership mode to bring cervical vaccine to Indian public sector at affordable rates.

“Our prime concern is that people should get medicine or vaccine at affordable rates and this tie up with Ministry of Health is a step in that direction,” he said.

Incorporated in year 2005, MSD Pharmaceuticals is a sales and marketing company set up here for distributing products of its US based parent company Merck & Co Merck sales for the year 2007 stood at USD 24.2 billion and product sales spanning 140 countries worldwide.